Charlene Son Rigby, CEO of Global Genes, talks about rare drug development, how patient advocates can contribute and drive the process, and the journey on the rare research roadmap.
Stay Connected
Sign up for updates straight to your inbox.
Charlene Son Rigby, CEO of Global Genes, talks about rare drug development, how patient advocates can contribute and drive the process, and the journey on the rare research roadmap.
Sign up for updates straight to your inbox.